Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
4.14
- 0.10 (-2.36%)
Day High: 4.25
Day Low:  4.11
Volume:    169,797
4:00 PM ET on Apr 23, 2018

Delayed at least 20 minutes.